COMMUNIQUÉS West-GlobeNewswire

Albireo to Present at Jefferies 2018 Global Healthcare Conference

29/05/2018 - 14:00

BOSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]

BioCryst Announces Presentation of Additional Analyses of the APeX-1 Clinical Trial of BCX7353 at the 2018 European Academy of Allergy and Clinical Immunology (EAACI) Congress

29/05/2018 - 14:00

RESEARCH TRIANGLE PARK, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, [...]

CASMED to Present at the 8th Annual LD Micro Invitational Conference on June 5

29/05/2018 - 14:00

BRANFORD, Conn., May 29, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief [...]

SCOUTCare™ Honored with Prestigious Aster Awards for Healthcare Communications

29/05/2018 - 14:00

Cianna Medical Continues to Expand Use of Innovative SAVI SCOUT® Technology and Supports Hospitals’ Mission to Become Wire-free Providers ALISO VIEJO, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Cianna Medical, Inc., the [...]

UroGen Pharma to Present at the Jefferies 2018 Global Healthcare Conference

29/05/2018 - 14:00

RA’ANANA, Israel and NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a [...]

FDA Clears Development Pathway for NexoBrid® for Sulfur Mustard Injuries

29/05/2018 - 14:00

YAVNE, Israel, May 29, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]

Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection

29/05/2018 - 14:00

AUSTIN, Texas, May 29, 2018 (GLOBE NEWSWIRE) -- Savara, Inc. (NASDAQ: SVRA ), an orphan lung disease company, today provided an update on two case reports exploring the use of aerosolized granulocyte-macrophage colony [...]

Intra-Cellular Therapies Announces Presentations on Lumateperone at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

29/05/2018 - 14:00

NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced [...]

Opiant Pharmaceuticals to Participate in The American Society of Clinical Psychopharmacology 2018 Annual Meeting

29/05/2018 - 14:00

Company’s Chief Scientific Officer, Phil Skolnick, Ph.D., to Receive ASCP’s “Donald Klein Lifetime Achievement Award” SANTA MONICA, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") ( [...]

Emerald Health Therapeutics Reports 1st Quarter 2018 Financial Results and Provides Corporate Update

29/05/2018 - 14:00

Commences commercial production at its Pure Sunfarms Delta 3 joint venture greenhouse operation VICTORIA, British Columbia, May 29, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V: EMH ) (OTCQX:EMHTF [...]

RedHill Biopharma Announces New U.S. Patent for its Experimental Ebola Therapy

29/05/2018 - 14:00

TEL-AVIV, Israel and RALEIGH, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

PolarityTE to host Key Opinion Leader Summit

29/05/2018 - 14:00

SALT LAKE CITY, May 29, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (Nasdaq: COOL ) today announced it will host a breakfast event in New York City with key opinion leaders (KOLs) to highlight the current treatment [...]

Elite Pharmaceuticals Announces Strategic Marketing Alliance with Glenmark Pharmaceuticals, Inc., USA

29/05/2018 - 13:30

NORTHVALE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc (OTCBB: ELTP ) announced today the signing of a license, manufacturing, and supply agreement with Glenmark Pharmaceuticals, Inc., USA to [...]

Evolus Appoints Veteran Healthcare Executive Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development

29/05/2018 - 13:30

IRVINE, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS ) (“Evolus” or the “Company”), a premiere aesthetics company, today announced the appointment of Lauren Silvernail as Chief Financial Officer [...]

Insider's tradings

29/05/2018 - 13:21

Nasdaq Copenhagen 29 May 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on the [...]

Bellicum Pharmaceuticals Appoints Shane Ward as General Counsel

29/05/2018 - 13:00

HOUSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Microbot Medical Announces Successful Completion of Pre-Clinical Study Performed at Washington University in St. Louis

29/05/2018 - 13:00

Significant Milestone Suggests Initial Safety Profile of the Self-Cleaning Shunt (SCS™) Product as the Company Moves Forward to Next Development Phase HINGHAM, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Microbot Medical [...]

Allergy Therapeutics plc - Positive new data with house-dust mite immunotherapy

29/05/2018 - 13:00

Al l ergy Therapeutics plc ("Allergy Therapeutics", the “Group” or “Company") Positive new clinical data with house-dust mite immunotherapy ~ House-dust mite immunotherapy shown to be well-tolerated and demonstrates [...]

Capricor Therapeutics to Present at the 2018 BIO International Convention in Boston

29/05/2018 - 13:00

LOS ANGELES, May 29, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ), a biotechnology company developing biological therapies for Duchenne muscular dystrophy and other rare disorders, today announced that [...]